Pieris Pharmaceuticals, Inc. (PIRS) NASDAQ

13.60

-2.51(-15.58%)

Updated at December 13, 2024 04:00PM

Currency In USD

Valuation

Market Cap30.27M
Enterprise Value-53.33M
P/E Ratio-4.29
PEG Ratio-2.82
Price/Sales Ratio-338.78
Price/Book Ratio3.89
Enterprise/Revenue860.6
Enterprise/EBITDA-16.23

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin661.62
Operating Margin-238.02

Management Effectiveness

Return On Assets-0.52
Return On Equity-0.69

Income Statement

Revenue0
Revenue/Share-0
Gross Profit0
EBITDA0
Net Income-17.43M
Diluted EPS-7.83

Balance Sheet

Total Cash63.57M
Total Cash/Share5.75
Total Debt0
Total Debt/Equity0
Current Ratio6.49
Book Value Per Share3.5

Price History

52-Week Change-4.96
52-Week High22.32
52-Week Low6.2
Moving Average 50 Days16.46
Moving Average 200 Days14.03

Statistics

Average Volume22,126
Shares Outstanding1.32M
% Held by Institutions1.08

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:80
Last Split DateApril 23, 2024